No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs189557288 |
chr21:40983149-40983150 |
Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs371512417 |
chr21:40983155-40983156 |
Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs375235530 |
chr21:40983161-40983162 |
Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs558091468 |
chr21:40983174-40983175 |
Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs578173639 |
chr21:40983288-40983289 |
Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs534208592 |
chr21:40983324-40983325 |
Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs554073807 |
chr21:40983359-40983360 |
Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs527547839 |
chr21:40983465-40983466 |
Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs114766187 |
chr21:40983479-40983480 |
Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs397867665 |
chr21:40983497-40983498 |
Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs112219111 |
chr21:40983540-40983541 |
Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs576075771 |
chr21:40983542-40983543 |
Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs111441453 |
chr21:40983552-40983553 |
Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs113876108 |
chr21:40983582-40983583 |
Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs539691865 |
chr21:40983621-40983622 |
Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs545151905 |
chr21:40983773-40983774 |
Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs138652672 |
chr21:40983779-40983780 |
Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs183265416 |
chr21:40983804-40983805 |
Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs563438598 |
chr21:40983867-40983868 |
Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs547709366 |
chr21:40984048-40984049 |
Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs561205818 |
chr21:40984079-40984080 |
Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs118064583 |
chr21:40984118-40984119 |
Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs565161106 |
chr21:40984119-40984120 |
Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs529264805 |
chr21:40984125-40984126 |
Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs187952036 |
chr21:40984148-40984149 |
Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs370598876 |
chr21:40984197-40984198 |
Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs374637226 |
chr21:40984278-40984279 |
Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs141178643 |
chr21:40984279-40984280 |
Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs371204587 |
chr21:40984280-40984281 |
Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs74789072 |
chr21:40984309-40984310 |
Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs190864220 |
chr21:40984323-40984324 |
Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs371688177 |
chr21:40984343-40984344 |
Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs571728450 |
chr21:40984359-40984360 |
Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs150259552 |
chr21:40984399-40984400 |
Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs139042793 |
chr21:40984442-40984443 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs539486727 |
chr21:40984445-40984446 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs113833591 |
chr21:40984446-40984447 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs567621094 |
chr21:40984452-40984453 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs77926611 |
chr21:40984509-40984510 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs555898624 |
chr21:40984519-40984520 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs576022941 |
chr21:40984561-40984562 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription
|
TF binding regionCpG islandlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs376699614 |
chr21:40984574-40984575 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription
|
TF binding regionCpG islandlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs544755540 |
chr21:40984609-40984610 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs561449867 |
chr21:40984614-40984615 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers
|
TF binding regionCpG islandlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs183583461 |
chr21:40984652-40984653 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers
|
TF binding regionCpG islandlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs558664236 |
chr21:40984653-40984654 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers
|
TF binding regionCpG islandlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs75427946 |
chr21:40984703-40984704 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers
|
TF binding regionCpG islandlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs369772690 |
chr21:40984712-40984713 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers
|
TF binding regionCpG islandlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs541237612 |
chr21:40984723-40984724 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers
|
TF binding regionCpG islandlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs373133724 |
chr21:40984790-40984791 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers
|
TF binding regionCpG islandlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|